Evidence map›Paper›PMID 41004462›Full record

ArticlePloS one2025

In-depth investigation into the binding capabilities of palladium-based N-heterocyclic carbenes towards five heavy metals: Hg, Cd, Pb, Cr, and As.

Qiao Liu, Xianghe Kong, Qian Ru Li, Wenbo Lan

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Qiao LiuSchool of Chemical Biology and Environmental Engineering, Xiangnan University, Chenzhou, Hunan, China.ORCID 0009-0006-2964-6966
Xianghe KongSchool of Chemistry and Chemical Engineering, University of South China, Hengyang, Hunan, China.
Qian Ru LiSchool of Public Health, Xiangnan University, Chenzhou, Hunan, China.
Wenbo LanSchool of Public Health, Xiangnan University, Chenzhou, Hunan, China.ORCID 0000-0002-7670-4798

Funding

Chenzhou City social science CZSSKL2016039 AND CZSSKL2024147Project of Natural Science Youth Foundation of Hunan Province 2023JJ40530Research Project of the Education Department of Hunan Province 23B0778, 21C0717Scientific Research Project of Xiangnan University 2018XJ23Teaching Reform Project of Ordinary Higher Education Institutions in Hunan Province HNJG-2021-0972
6 · The paper itself

Abstract

Given the severe environmental and health risks posed by heavy metal pollutants such as mercury (Hg), cadmium (Cd), lead (Pb), chromium (Cr), and arsenic (As), the development of highly efficient and selective capture materials is critically important.This study explores the molecular structural characteristics of complexes formed by substituting the central palladium atom in nitrogen-heterocyclic carbene complexes with mercury (Hg), cadmium (Cd), lead (Pb), chromium (Cr), and arsenic (As). For all the complexes, the simulated infrared and ultraviolet-visible spectra, Wiberg bond indices, as well as the binding ability of nitrogen-heterocyclic carbene ligands to the central atom were assessed. The results show that the complexes obtained when the central atom is replaced by Hg, Cd, Pb, Cr, or As are stable and display unique spectral features. Significantly, nitrogen-heterocyclic carbene has the strongest binding affinity for Pd. The complexes of chromium substitutes possess relatively high chemical stability. These findings will offer important references for future pollution control and support the specific capture of the five studied heavy metals, and enrichment of Cr using nitrogen-heterocyclic carbene ligands.

Indexed as

Heterocyclic CompoundsMetals, HeavyMethanePalladiumArsenicCadmiumChromiumLeadLigandsMercuryArsenicCadmiumcarbeneChromiumHeterocyclic CompoundsLeadLigandsMercuryMetals, HeavyMethanePalladium

Identifiers

PMID41004462
PMCPMC12469149

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.